
Ko Hung Chan
Examiner (ID: 11956, Phone: (571)272-6816 , Office: P/3631 )
| Most Active Art Unit | 3631 |
| Art Unit(s) | 3632, 3505, 2899, 3637, 3631 |
| Total Applications | 2366 |
| Issued Applications | 1619 |
| Pending Applications | 110 |
| Abandoned Applications | 657 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18266021
[patent_doc_number] => 20230087263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/800032
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800032 | Anti-CD19/anti-CD3 bispecific antibody, T cells secreting the same, method of preparation and use thereof | Feb 15, 2021 | Issued |
Array
(
[id] => 17649941
[patent_doc_number] => 11352655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Method of identification of methicillin-resistant
[patent_app_type] => utility
[patent_app_number] => 17/170912
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 4914
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170912 | Method of identification of methicillin-resistant | Feb 8, 2021 | Issued |
Array
(
[id] => 17792532
[patent_doc_number] => 20220251623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Method and apparatus for avoiding false positive coliform testing
[patent_app_type] => utility
[patent_app_number] => 17/300020
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300020 | Method and apparatus for avoiding false positive coliform testing | Feb 8, 2021 | Abandoned |
Array
(
[id] => 18452056
[patent_doc_number] => 20230193335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => HMO PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/759270
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759270 | HMO PRODUCTION | Jan 21, 2021 | Pending |
Array
(
[id] => 16822764
[patent_doc_number] => 20210138057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => Anti-Microbial Immunomodulation
[patent_app_type] => utility
[patent_app_number] => 17/154536
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154536 | Anti-microbial immunomodulation | Jan 20, 2021 | Issued |
Array
(
[id] => 18780187
[patent_doc_number] => 11821898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Rapid test for Lyme bacteria
[patent_app_type] => utility
[patent_app_number] => 17/152146
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5537
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152146 | Rapid test for Lyme bacteria | Jan 18, 2021 | Issued |
Array
(
[id] => 18196706
[patent_doc_number] => 20230050225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Vaccines targeting Neisseria gonorrhoeae
[patent_app_type] => utility
[patent_app_number] => 17/791038
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791038 | Vaccines targeting Neisseria gonorrhoeae | Jan 5, 2021 | Pending |
Array
(
[id] => 18504859
[patent_doc_number] => 11702664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/127530
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 33
[patent_no_of_words] => 42815
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127530
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127530 | Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof | Dec 17, 2020 | Issued |
Array
(
[id] => 18126519
[patent_doc_number] => 20230012140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => ORAL RESPIRATORY VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/783228
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783228 | ORAL RESPIRATORY VACCINE | Dec 16, 2020 | Issued |
Array
(
[id] => 16791738
[patent_doc_number] => 20210121555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/125555
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125555 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | Dec 16, 2020 | Pending |
Array
(
[id] => 18180482
[patent_doc_number] => 20230041211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => DECREASING TOXICITY OF TERPENES AND INCREASING THE PRODUCTION POTENTIAL IN MICRO-ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/786127
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786127 | DECREASING TOXICITY OF TERPENES AND INCREASING THE PRODUCTION POTENTIAL IN MICRO-ORGANISMS | Dec 14, 2020 | Pending |
Array
(
[id] => 17198674
[patent_doc_number] => 20210338768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITION COMPRISING OIL DROPS
[patent_app_type] => utility
[patent_app_number] => 17/118391
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118391 | COMPOSITION COMPRISING OIL DROPS | Dec 9, 2020 | Abandoned |
Array
(
[id] => 18064477
[patent_doc_number] => 20220395564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS
[patent_app_type] => utility
[patent_app_number] => 17/779633
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779633
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779633 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS | Nov 24, 2020 | Pending |
Array
(
[id] => 17123541
[patent_doc_number] => 20210298309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => NOVEL PROTECTIVE BARRIER COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/103392
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/103392 | Protective barrier compositions and uses thereof | Nov 23, 2020 | Issued |
Array
(
[id] => 16726535
[patent_doc_number] => 20210093682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Lactobacillus Gasseri KBL697 Strain and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/102301
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102301 | None | Nov 22, 2020 | Issued |
Array
(
[id] => 18215264
[patent_doc_number] => 11590177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Methods of treating cancer using bacteria expressing c-di-AMP
[patent_app_type] => utility
[patent_app_number] => 16/953162
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 70
[patent_no_of_words] => 7754
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953162
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/953162 | Methods of treating cancer using bacteria expressing c-di-AMP | Nov 18, 2020 | Issued |
Array
(
[id] => 18091339
[patent_doc_number] => 20220409680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => NEW FORMULATION OF LACTOBACILLUS STRAINS FOR THE TREATMENT AND PREVENTION OF HELICOBACTER PYLORI COLONISATION IN THE UPPER AIRWAYS AND THE DIGESTIVE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/777075
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777075 | NEW FORMULATION OF LACTOBACILLUS STRAINS FOR THE TREATMENT AND PREVENTION OF HELICOBACTER PYLORI COLONISATION IN THE UPPER AIRWAYS AND THE DIGESTIVE SYSTEM | Nov 15, 2020 | Abandoned |
Array
(
[id] => 18355060
[patent_doc_number] => 11643450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
[patent_app_type] => utility
[patent_app_number] => 17/097534
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 43
[patent_no_of_words] => 14445
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/097534 | Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof | Nov 12, 2020 | Issued |
Array
(
[id] => 16839507
[patent_doc_number] => 20210147519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND A STAPHYLOCOCCUS TARGET ANTIGEN AND A COMPLEMENT COMPONENT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/097371
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/097371 | BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND A STAPHYLOCOCCUS TARGET ANTIGEN AND A COMPLEMENT COMPONENT AND USES THEREOF | Nov 12, 2020 | Abandoned |
Array
(
[id] => 17020937
[patent_doc_number] => 20210244808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHODS FOR INHIBITING BIOFILM FORMATION
[patent_app_type] => utility
[patent_app_number] => 17/093396
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/093396 | METHODS FOR INHIBITING BIOFILM FORMATION | Nov 8, 2020 | Abandoned |